| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 03/21/2002 | US20020035266 Tetrazolyl-phenyl acetamide glucokinase activators |
| 03/21/2002 | CA2422044A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 03/21/2002 | CA2357469A1 Process for producing non-proteinogenic l-amino acids by fermentation |
| 03/20/2002 | EP1187818A1 Pesticidally active tetrazine derivatives |
| 03/20/2002 | CN1081186C Process for preparing 1,4,7,10-tetraazacyclododecane and its derivatives |
| 03/19/2002 | US6358960 For therapy of intravascular coagulation, coronary thrombosis, cerebral infarction, cerebral embolism, transient ischemic attack, cerebrovascular disorders, pulmonary vascular diseases, deep venous thrombosis, etc. |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |
| 03/19/2002 | CA1341349C Functionalized polyamine chelants and rhodium complexes thereof for conjugation to antibodies |
| 03/14/2002 | WO2002020474A2 Resorcinol derivatives |
| 03/14/2002 | US20020032227 Oxime derivative and bactericide containing the same as active ingredient |
| 03/14/2002 | US20020032210 Chloride channel blockers; useful in the treatment of sickle cell anaemia, brain edema following iscaemia or tumors, diarrhea, hypertension, bone metabolic disorders, osteoclast associated disoders; substituted biphenyl containing nitrogen |
| 03/14/2002 | US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355799 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
| 03/12/2002 | US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents |
| 03/07/2002 | WO2002018455A1 Resins having vinyl ether linker for the solid phase organic synthesis |
| 03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
| 03/07/2002 | WO2001089457A3 Thrombopoietin mimetics |
| 03/07/2002 | US20020028971 Mineral acid other than nitric acid (hydrchloric acid) increases the rate of aluminum digestion without use of solvent; useful in solid rocket motor propellants, explosives, and pyrotechnics |
| 03/07/2002 | US20020028970 Oxidizing a diamidodiol to form a diacid followed by coupling with an aryl diamine |
| 03/07/2002 | DE10040783A1 AZA-Aminosäurederivate (Faktor X¶a¶-Inhibitoren 15) AZA-amino acid derivatives (factor inhibitors X¶a¶ 15) |
| 03/06/2002 | EP1184377A1 Hepatobiliary magnetic resonance contrast agents |
| 03/06/2002 | EP1183255A1 Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging |
| 03/06/2002 | EP1183246A1 Tetrazolinone derivatives |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | CN1338933A Methods and compositions to enhance white blood cell count |
| 03/06/2002 | CN1080257C Guanidine derivatives |
| 02/28/2002 | WO2002016330A1 Macrocyclic tetraamido ligands as bleaching catalysts and synthesis thereof |
| 02/28/2002 | WO2002016315A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/28/2002 | CA2419864A1 Macrocyclic tetraamido ligands as bleaching catalysts and synthesis thereof |
| 02/28/2002 | CA2415838A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/27/2002 | EP1181271A2 Naphthalene ureas as glucose uptake enhancers |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1079679C Cascade polymer complexes, its preparation process and medicine containing said complexes |
| 02/26/2002 | US6350767 Growth hormone release stimulant |
| 02/26/2002 | CA2081605C Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent |
| 02/21/2002 | WO2002014312A1 Tetrazolyl-phenyl acetamide glucokinase activators |
| 02/21/2002 | WO2002014283A1 Processes for preparing cilostazol |
| 02/21/2002 | WO2002013875A2 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/21/2002 | US20020022648 Novel 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists |
| 02/21/2002 | US20020022647 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
| 02/21/2002 | CA2419259A1 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 02/21/2002 | CA2419181A1 Processes for preparing cilostazol |
| 02/14/2002 | WO2002012224A2 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | WO2002012214A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/14/2002 | WO2002012190A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | CA2419036A1 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 02/14/2002 | CA2419027A1 Bicyclic compounds as h3 receptor ligands |
| 02/14/2002 | CA2418369A1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 02/13/2002 | EP1178975A1 Gadolinium complex tetramides and use in medical imaging |
| 02/13/2002 | EP0691961B1 Substituted caprolactams and derivatives thereof useful for treatment of hiv disease |
| 02/13/2002 | CN1335840A Novel tetrazolinone derivatives |
| 02/12/2002 | US6346532 Antidiabetic, antilipemic, and hypoglycemic agents; adrenergic stimulants |
| 02/12/2002 | CA2053705C Piperazine derivatives |
| 02/07/2002 | WO2002010177A1 Ammonium salts of inositol hexaphosphate and uses thereof |
| 02/07/2002 | WO2002010142A1 Cyclic polyamine compounds for cancer therapy |
| 02/07/2002 | WO2002009651A2 Fatty acid synthase inhibitors |
| 02/07/2002 | US20020016368 Administering to a mammal a therapeutically effective amount of a compound of sulfonamide or alkanoy or amide derivative containing hetero or aromatic rings to treat osteoporosis, osteotomy, childhood idiopathic boen loss etc. |
| 02/07/2002 | US20020016326 Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors |
| 02/07/2002 | DE10037146A1 Acetamidderivate Acetamide derivatives |
| 02/07/2002 | CA2417064A1 Cyclic polyamine compounds for cancer therapy |
| 02/06/2002 | EP1177187A1 Di-aryl acid derivatives as ppar receptor ligands |
| 02/06/2002 | CN1334807A 1-heterocycle substd. diarylamines |
| 02/05/2002 | US6344485 Method for treating glaucoma |
| 02/05/2002 | US6344213 Compounds and compositions for delivering active agents |
| 02/05/2002 | CA2123403C Acyclic ethylenediamine derivatives as substance p receptor antagonists |
| 01/31/2002 | WO2002008189A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | US20020013370 Methods for identifying and treating resistant tumors |
| 01/31/2002 | CA2417127A1 Compounds and inhibitors of phospholipases |
| 01/30/2002 | EP1175383A1 Glucocorticoid receptor modulators |
| 01/30/2002 | EP1175213A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/29/2002 | US6342598 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| 01/29/2002 | US6342597 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid derivatives as chelating agents |
| 01/29/2002 | US6342589 Reacting 3,6-bis(3,5-dimethylpyrazol-1-yl)-1,2,4,5-tetrazine with hydrazine; further reacting with n-bromosuccinimide in acetonitrile |
| 01/29/2002 | US6342508 N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/24/2002 | WO2002006254A1 Tetrazole derivatives |
| 01/24/2002 | WO2002006253A1 Valsartan salts |
| 01/24/2002 | WO2001082780A3 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents |
| 01/24/2002 | WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 01/24/2002 | US20020010213 Inhibiting membrane transport mediated by the multidrug resistance associated protein MRP in a patient by administering a compound having an amphiphilic anion and a molecular weight of from 300 to 950 daltons. |
| 01/24/2002 | CA2415673A1 Tetrazole derivatives |
| 01/22/2002 | US6340706 Antiinflammatory, antiallergic and antiproliferative agents |
| 01/17/2002 | WO2002004412A2 Tyrosine derivatives as phosphatase inhibitors |
| 01/17/2002 | US20020006946 Obesity, antidiabetic agents, cardiovascular disorders |
| 01/17/2002 | US20020006922 Metalloprotease inhibitors |
| 01/15/2002 | US6339042 Herbicidal N-cyclohexadienyl heteroaryloxyacetamides |
| 01/10/2002 | WO2002002536A1 Novel tetrazole derivatives |
| 01/10/2002 | WO2001052900A3 Novel orthogonally protected amino acid chelators for biomedical applications |
| 01/10/2002 | CA2414879A1 Novel tetrazole derivatives |
| 01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | CN1329603A Method of producing tricyclene |
| 01/02/2002 | CN1328824A Compound for curing female sexual disorder |
| 01/01/2002 | US6335459 Prostaglandin i2 receptor modulators; treating tissue necrosis, premature uterine contraction, gastric ulceration, sexual dysfunction, menstrual pain and improper wound healing, immunoregulation, platelet aggregation or neutrophil function |
| 01/01/2002 | US6335366 A prostaglandin e2 antagonist or agonist which comprises a naphthylhydroxy derivatives or naphthyloxyalkylene derivatives or nontoxic salts |